Natixis Advisors LLC Buys 21,075 Shares of Corteva, Inc. $CTVA

Posted by Brian Himes on Jun 4th, 2026

Natixis Advisors LLC grew its stake in shares of Corteva, Inc. (NYSE:CTVA – Free Report) by 3.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 657,702 shares of the company’s stock after purchasing an additional 21,075 shares during the period. Natixis Advisors LLC owned approximately 0.10% of Corteva worth $44,086,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. JPL Wealth Management LLC bought a new stake in shares of Corteva during the 3rd quarter valued at about $25,000. Redmont Wealth Advisors LLC bought a new stake in shares of Corteva during the 3rd quarter valued at about $29,000. Basepoint Wealth LLC bought a new stake in shares of Corteva during the 4th quarter valued at about $30,000. Jackson Grant Investment Advisers Inc. boosted its stake in shares of Corteva by 90.6% during the 3rd quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock valued at $30,000 after purchasing an additional 213 shares in the last quarter. Finally, Measured Wealth Private Client Group LLC bought a new stake in shares of Corteva during the 3rd quarter valued at about $33,000. Institutional investors own 81.54% of the company’s stock.

Corteva Trading Up 0.5%

NYSE:CTVA opened at $77.93 on Thursday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. The firm has a market capitalization of $52.12 billion, a P/E ratio of 45.84, a PEG ratio of 2.37 and a beta of 0.57. Corteva, Inc. has a one year low of $60.53 and a one year high of $85.63. The company’s 50-day simple moving average is $81.33 and its 200 day simple moving average is $74.84.

Corteva (NYSE:CTVA – Get Free Report) last issued its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.32. The business had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same period in the previous year, the company earned $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, analysts forecast that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be issued a $0.18 dividend. The ex-dividend date of this dividend is Monday, June 1st. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s payout ratio is 42.35%.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on CTVA. Argus lifted their target price on shares of Corteva from $80.00 to $91.00 and gave the company a “buy” rating in a research note on Tuesday, March 31st. Berenberg Bank boosted their price objective on shares of Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a research note on Thursday, March 26th. UBS Group boosted their price objective on shares of Corteva from $88.00 to $90.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. Wolfe Research boosted their price objective on shares of Corteva from $81.00 to $86.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. Finally, Morgan Stanley boosted their price objective on shares of Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 28th. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $88.67.

View Our Latest Stock Analysis on Corteva

About Corteva

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.